Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2856-2864

  Garden, Adam S ^a   Harris, J ^a   Vokes, E E ^a   Forastiere, A A ^a   Ridge, J A ^a   Jones, C ^a   Horwitz, E M ^a   Glisson, B S ^a   Nabell, L ^a   Cooper, J S ^a   Demas, W ^a   Gore, E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; ADULT; AGED; FEASIBILITY STUDY; FEMALE; HEAD AND NECK TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4344639820     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.12.012     Document Type: Article

References (36)

1. Vokes EE, Weichselbaum RR, Lippman SM, et al: Medical progress: Head and neck cancer. N Engl J Med 328:184-194, 1993
2. Fu KK, Phillips TL, Silverberg IJ: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987
3. Taylor SG, Murthy AK, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
4. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997
5. Brizel DM, Leopold KA, Fisher SR, et al: A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 28:213-220, 1994
6. Stefani S, Eells RW, Abbate J: Hydroxyurea and radiotherapy in head and neck cancer. Radiology 101:391-396, 1971
7. Haffty BG, Son YH, Papac R, et al: Chemotherapy as an adjunct to radiation therapy in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials. J Clin Oncol 15:268-276, 1997
8. Al-Sarraf M, LeBlanc M, Giri P, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16:1310-1317, 1998
9. Haselow RE, Warshaw MG, Oken MM, et al: Radiation alone versus radiation with weekly low dose cisplatinum in unresectabel cancer of the head and neck, in Fee W, Goepfert H, Johns M, et al (eds): Head and Neck Cancer. Toronto, Canada, Decker, 1990, pp 279-281
10. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000
11. Vokes EE, Panje WR, Schilsky RL, et al: Hydroxyurea, 5-fluorouracil and concomitant radiotherapy in poor prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761-768, 1989
12. Marcial VA, Pajak TF, Mohiuddin M, et al: Concommitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66:1861-1868, 1990
13. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999
14. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998
15. Simon R, Wittes R, Ellenberg S: Randomized phase II clinical trials. Cancer Treat Rep 69:1375-1381, 1985
16. Garden AS, Glisson BS, Ang KK, et al: Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses. J Clin Oncol 17:2390-2395, 1999
17. Haraf DJ, Kies M, Rademaker AW, et al: Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer. J Clin Oncol 17:638-644, 1999
18. Flood W, Lee DJ, Trotti A, et al: Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: Preliminary results of two pilot trials using paclitaxel and cisplatin. Semin Radiat Oncol 9:64-69, 1999
19. Zelen M: The randomization and stratification of patients to clinical trials. J Chron Dis 27:365-375, 1974
20. Trotti A, Byhardt R, Stetz J, et al: Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13-47, 2000
21. Cox J, Stetz J, Pajak T: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 32:567-576, 1995
22. Kaplan EL, Meier P: Nonparameteric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
24. Kalbfleish J, Prentice R: The statistical analysis of failure time data. New York, NY, John Wiley and Sons, 1980
25. Cox DR: Regression models and life tables. J Royal Stat Soc Series B 34:187-229, 1972
26. Cooper JS, Berkey B, Marcial V, et al: Validation of the RTOG Recursive Partitioning Classification for head and neck tumors. Head Neck 23:669-677, 2001
27. Fu KK, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000
28. Wong WW, Mick R, Haraf DJ, et al: Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 29:153-162, 1994
29. Kies M, Haraf D, Rosen F, et al: Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19:1961-1969, 2001
30. Vokes E, Stenson K, Rosen F, et al: Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21:320-326, 2003
31. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
32. Adelstein DJ, Li Y, Adams GL, et al: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98, 2003
33. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data-MACH-NC Collaborative Group: Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949-955, 2000
34. Adelstein DJ, Saxton JP, Lavertu P, et al: Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 20:1405-1410, 2002
35. Poole ME, Sailer SL, Rosenman JG, et al: Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation. Arch Otolaryngol Head Neck Surg 127:1446-1450, 2001
36. Ang KK, Harris J, Garden AS, et al: Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas: Preliminary results of a phase II trial of the RTOG (99-14). Int J Radiat Oncol Biol Phys 54:71, 2002